Clinical Trial Update: Role of Enteral Lactoferrin as an Adjuvant for Prevention of Sepsis Among Preterm Neonates [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating enteral lactoferrin as an adjuvant to prevent sepsis in preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Zartash Sial Paeds Med | Conditions: Sepsis | Phase 1 | Status: COMPLETED